Advertisement
Home 2019 March

Monthly Archives: March 2019

Increased use of tourniquets

Three Interventions Involved in Decrease in Combat Mortality

Increased use of tourniquets, blood transfusions, rapid prehospital transport time key to mortality reduction
Having a shorter reproductive span is associated with an increased risk for dementia in women

Shorter Reproductive Span May Up Risk for Dementia in Women

Dementia risk increased for menarche age ≥16 versus 13.0 years, natural menopause at <47.4 years
The incidence and point prevalence of visual problems in acute stroke survivors are very high

High Rates of Visual Problems Seen in Stroke Survivors

Three-quarters have visual problems, including impaired central vision, eye movement abnormalities
Recommendations have been developed for the use of genetic testing in psychiatric care

Recommendations Presented on Genetic Testing in Psychiatry

Guidelines emphasize that common genetic variants are not sufficient to cause psychiatric disorders
A simple point-of-care urine test can rapidly detect preeclampsia

Simple Rapid Urine Test Can Help Diagnose Preeclampsia

Test outperforms other proposed diagnostic markers, with 86.7 percent accuracy
Cimzia (certolizumab pegol) injection has been approved to treat adults with nonradiographic axial spondyloarthritis with objective signs of inflammation

Cimzia Injection Approved for New Inflammatory Arthritis Indication

FDA grants approval for first treatment for nonradiographic axial spondyloarthritis
A California man who said that Monsanto's weedkiller Roundup caused his cancer was awarded $80 million in damages by a jury in San Francisco on Wednesday.

California Man Awarded $80 Million in Roundup Lawsuit

Jury previously found Roundup was a significant factor in plaintiff's non-Hodgkin lymphoma
Lifetime risks for hypertension under the American Heart Association and American College of Cardiology 2017 threshold exceed 75 percent for white men and African-American men and women

Lifetime HTN Risk High for Black Men and Women, White Men

Lifetime risks are higher under AHA/ACC 2017 HTN threshold than JNC7 threshold for hypertension

Endocrine Society, March 23-26

The Endocrine Society 101st Annual Meeting and Expo The annual meeting of the Endocrine Society (ENDO 2019) was held from March 23 to...
Adding docetaxel-based chemotherapy to standard treatment for high-risk nonmetastatic prostate cancer improves survival

Docetaxel Chemo Ups Survival in High-Risk Localized Prostate Cancer

Findings based on addition of docetaxel chemotherapy to androgen suppression, radiotherapy